Serum interleukin-8 in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Immunology
• Biochemistry

Background:

• Inflammatory bowel disease (IBD) encompasses Crohn's disease and ulcerative colitis, characterized by chronic gastrointestinal inflammation.
• Interleukin-8 (IL-8) is a pro-inflammatory cytokine implicated in various inflammatory conditions.
• Accurate markers for IBD disease activity are crucial for effective patient management.

Purpose of the Study:

• To investigate the association between serum interleukin-8 (IL-8) concentrations and disease activity in patients with inflammatory bowel disease (IBD).
• To compare IL-8 levels with plasma interleukin-6 (IL-6) and assess IL-8 changes following dietary intervention.

Main Methods:

• Serum IL-8 concentrations were measured using enzyme-linked immunosorbent assay (ELISA) in 93 IBD patients.
• IL-8 levels were compared between active and inactive disease states, and correlated with disease severity scores.
• IL-8 levels were also assessed in Crohn's disease patients before and after polymeric diet treatment and compared with IL-6 levels.

Main Results:

• Serum IL-8 levels were significantly higher in patients with active ulcerative colitis compared to inactive disease (P < 0.05).
• IL-8 concentrations correlated with disease severity and extent scores (P = 0.01).
• No significant difference in IL-8 levels was observed between active and inactive Crohn's disease; no correlation was found between serum IL-8 and plasma IL-6.

Conclusions:

• While serum IL-8 may play a role in the inflammatory processes of IBD, it is not a reliable indicator of disease activity.
• Dietary treatment led to a significant reduction in serum IL-8 levels in Crohn's disease patients.
• Further research may explore the specific role of IL-8 in IBD pathogenesis and its potential as a therapeutic target.